{"id":"0da18225-1c12-408c-935e-49a5abb3807b","modelId":"cd51c658-641a-4d09-b0ac-57aaf6874f42","versionId":null,"locationId":"aad1b278-b2b9-403b-bb76-236326bd3181","operatorId":"02ead9de-6bce-472d-9e76-d9c954d8d603","ownerId":null,"slug":"liberty-endovascular-miami-florida-usa","status":"pilot","firstSeen":"2024-07-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"small_2_10","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medical-partners-baptist-hospital-miami-participate-its","name":"Microbot Medical Investor Relations","title":"Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial"}],"notes":"Microbot Medical partnered with Baptist Hospital of Miami as the second clinical trial site for the LIBERTY pivotal human clinical trial. Data presented by Constantino Peña, MD from Miami Cardiac and Vascular Institute at Baptist Hospital.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"pilot_lt10","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-08T22:32:43.176Z","updatedAt":"2026-08-21T17:09:40.514Z","model":{"id":"cd51c658-641a-4d09-b0ac-57aaf6874f42","companyId":"02ead9de-6bce-472d-9e76-d9c954d8d603","modelName":"LIBERTY Endovascular Robotic System","slug":"liberty-endovascular","description":"Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"createdAt":"2026-07-02T21:26:26.322Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"02ead9de-6bce-472d-9e76-d9c954d8d603","name":"Microbot Medical","slug":"microbot-medical","description":"Microbot Medical Inc. (Nasdaq: MBOT) is a commercial-stage medical device company developing the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The company received FDA 510(k) clearance in September 2025 and commenced limited market release in November 2025, expanding to a full market release in Q2 2026. Headquartered in Hingham, Massachusetts with R&D operations in Yokneam, Israel.","status":"public","founded":2011,"hq":"Hingham, MA, USA","hqLat":42.2417669,"hqLng":-70.8897676,"hqGeocodedAt":"2026-08-05T00:51:16.415Z","hqAddress":null,"hqPrecision":null,"website":"microbotmedical.com","fundingTotal":"92200000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"MBOT","stockExchange":"NASDAQ","secCik":"0000883975","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-02T21:26:26.164Z","updatedAt":"2026-08-21T22:25:39.297Z"}},"version":null,"location":{"id":"aad1b278-b2b9-403b-bb76-236326bd3181","name":"Miami, Florida, USA","slug":"miami-florida-usa","kind":"city","parentLocationId":null,"region":"Southeast","lat":25.7617,"lng":-80.1918,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-08T22:32:42.793Z","updatedAt":"2026-08-27T18:09:38.905Z"},"operator":{"id":"02ead9de-6bce-472d-9e76-d9c954d8d603","name":"Microbot Medical","slug":"microbot-medical","description":"Microbot Medical Inc. (Nasdaq: MBOT) is a commercial-stage medical device company developing the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The company received FDA 510(k) clearance in September 2025 and commenced limited market release in November 2025, expanding to a full market release in Q2 2026. Headquartered in Hingham, Massachusetts with R&D operations in Yokneam, Israel.","status":"public","founded":2011,"hq":"Hingham, MA, USA","hqLat":42.2417669,"hqLng":-70.8897676,"hqGeocodedAt":"2026-08-05T00:51:16.415Z","hqAddress":null,"hqPrecision":null,"website":"microbotmedical.com","fundingTotal":"92200000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"MBOT","stockExchange":"NASDAQ","secCik":"0000883975","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-02T21:26:26.164Z","updatedAt":"2026-08-21T22:25:39.297Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/liberty-endovascular-miami-florida-usa","url":"https://registry.deploy.report/deployments/liberty-endovascular-miami-florida-usa","name":"LIBERTY Endovascular Robotic System at Miami, Florida, USA","identifier":"0da18225-1c12-408c-935e-49a5abb3807b","startDate":"2024-07-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/miami-florida-usa","name":"Miami, Florida, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/microbot-medical","name":"Microbot Medical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/liberty-endovascular","name":"LIBERTY Endovascular Robotic System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":["primary-company-ir"]}}}